An update on the prognosis of patients with atrial fibrillation.
作者信息
McManus David D, Rienstra Michiel, Benjamin Emelia J
机构信息
National Heart Lung and Blood Institute's and Boston University's Framingham Heart Study, Framingham, MA, USA.
出版信息
Circulation. 2012 Sep 4;126(10):e143-6. doi: 10.1161/CIRCULATIONAHA.112.129759.
Abstract
摘要
相似文献
1
An update on the prognosis of patients with atrial fibrillation.心房颤动患者预后的最新情况。
Circulation. 2012 Sep 4;126(10):e143-6. doi: 10.1161/CIRCULATIONAHA.112.129759.
2
Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis.心房颤动与心血管疾病、肾脏疾病和死亡风险：系统评价和荟萃分析。
BMJ. 2016 Sep 6;354:i4482. doi: 10.1136/bmj.i4482.
3
Cardiovascular Events after New-Onset Atrial Fibrillation in Adults with CKD: Results from the Chronic Renal Insufficiency Cohort (CRIC) Study.慢性肾脏病患者新发心房颤动后的心血管事件：慢性肾功能不全队列（CRIC）研究结果。
J Am Soc Nephrol. 2018 Dec;29(12):2859-2869. doi: 10.1681/ASN.2018050514. Epub 2018 Oct 30.
4
High overall cardiovascular risk and mortality in patients with atrial fibrillation and diabetes: A nationwide report.心房颤动合并糖尿病患者的总体心血管风险和死亡率：一项全国性报告。
Diab Vasc Dis Res. 2018 Jan;15(1):31-38. doi: 10.1177/1479164117735013. Epub 2017 Oct 20.
5
Cardiovascular outcomes among elderly patients with heart failure and coronary artery disease and without atrial fibrillation: a retrospective cohort study.老年心力衰竭合并冠心病且无房颤患者的心血管结局：一项回顾性队列研究。
BMC Cardiovasc Disord. 2019 Jan 15;19(1):19. doi: 10.1186/s12872-018-0991-1.
6
Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation?慢性肾脏病是否提高 CHADS2 和 CHA2DS2-VASc 卒中分层风险评分预测房颤的价值？
Thromb Haemost. 2013 May;109(5):956-60. doi: 10.1160/TH13-01-0054. Epub 2013 Mar 21.
7
Atrial fibrillation and the risk for myocardial infarction, all-cause mortality and heart failure: A systematic review and meta-analysis.心房颤动与心肌梗死、全因死亡率和心力衰竭风险：系统评价和荟萃分析。
Eur J Prev Cardiol. 2017 Sep;24(14):1555-1566. doi: 10.1177/2047487317715769. Epub 2017 Jun 15.
8
Association between impaired renal function and stroke outcome in patients with versus without atrial fibrillation.肾功能障碍与伴有和不伴有心房颤动的脑卒中患者预后的相关性。
Eur J Neurol. 2018 Aug;25(8):1041-1048. doi: 10.1111/ene.13617. Epub 2018 Apr 6.
9
The association of anticoagulation, ischemic stroke, and hemorrhage in elderly adults with chronic kidney disease and atrial fibrillation.老年慢性肾脏病合并心房颤动患者抗凝、缺血性卒中和出血的相关性。
Kidney Int. 2017 Apr;91(4):928-936. doi: 10.1016/j.kint.2016.10.017. Epub 2016 Dec 22.
10
Atrial Fibrillation and Cardiovascular Outcomes in the Elderly.老年人的心房颤动与心血管结局
Pacing Clin Electrophysiol. 2016 Sep;39(9):907-13. doi: 10.1111/pace.12907. Epub 2016 Jul 26.
引用本文的文献
1
Effectiveness of Immediate Pharmacological Versus Electrical Cardioversion on Hemodynamic Stability and Rhythm Restoration in Patients With Refractory Atrial Fibrillation: A Systematic Review.即时药物复律与电复律对难治性心房颤动患者血流动力学稳定性和心律恢复的有效性：一项系统评价
Cureus. 2025 Jun 25;17(6):e86747. doi: 10.7759/cureus.86747. eCollection 2025 Jun.
2
Pathophysiology, Diagnosis, and Management of Coronary Artery Disease in the Setting of Atrial Fibrillation.心房颤动背景下冠状动脉疾病的病理生理学、诊断与管理
J Am Heart Assoc. 2024 Dec 3;13(23):e037552. doi: 10.1161/JAHA.124.037552. Epub 2024 Nov 22.
3
P-wave terminal force in lead V1 is associated with recurrence after catheter ablation in patients with paroxysmal atrial fibrillation and normal left atrial size.阵发性心房颤动且左心房大小正常的患者，V1导联P波终末电势与导管消融术后复发相关。
Front Cardiovasc Med. 2024 Oct 10;11:1467585. doi: 10.3389/fcvm.2024.1467585. eCollection 2024.
4
Comparison between non-vitamin K oral antagonist versus warfarin in atrial fibrillation with and without valvular heart disease: a systematic review and meta-analysis.非维生素K口服抗凝剂与华法林在伴或不伴有心脏瓣膜病的心房颤动患者中的比较：一项系统评价和荟萃分析。
Egypt Heart J. 2024 Aug 9;76(1):102. doi: 10.1186/s43044-024-00535-w.
5
Editorial: New discoveries on calcium handling in cardiovascular pathology.社论：心血管病理学中钙处理的新发现
Front Cardiovasc Med. 2024 Jul 17;11:1461311. doi: 10.3389/fcvm.2024.1461311. eCollection 2024.
6
Chronic Partial Sleep Deprivation Increased the Incidence of Atrial Fibrillation by Promoting Pulmonary Vein and Atrial Arrhythmogenesis in a Rodent Model.慢性部分睡眠剥夺通过促进肺静脉和心房心律失常发生增加了房颤的发生率。
Int J Mol Sci. 2024 Jul 11;25(14):7619. doi: 10.3390/ijms25147619.
7
Incremental value of diastolic wall strain in predicting heart failure events in patients with atrial fibrillation.舒张期壁应变对预测心房颤动患者心力衰竭事件的增量价值。
Heart Vessels. 2024 Sep;39(9):785-794. doi: 10.1007/s00380-024-02401-w. Epub 2024 Apr 16.
8
Application of Photodynamic Therapy in Cardiology.光动力疗法在心脏病学中的应用。
Int J Mol Sci. 2024 Mar 11;25(6):3206. doi: 10.3390/ijms25063206.
9
Serum electrolyte concentrations and risk of atrial fibrillation: an observational and mendelian randomization study.血清电解质浓度与心房颤动风险：观察性和孟德尔随机化研究。
BMC Genomics. 2024 Mar 16;25(1):280. doi: 10.1186/s12864-024-10197-2.
10
The incidence and impact of atrial fibrillation on hospitalized Coronavirus disease-2019 patients.因 COVID-19 住院患者中房颤的发生率及其影响。
Clin Cardiol. 2024 Feb;47(2):e24240. doi: 10.1002/clc.24240.
本文引用的文献
1
Novel risk factors for atrial fibrillation: useful for risk prediction and clinical decision making?心房颤动的新型危险因素：对风险预测和临床决策是否有用？
Circulation. 2012 May 22;125(20):e941-6. doi: 10.1161/CIRCULATIONAHA.112.112920.
2
Added predictive ability of the CHA2DS2VASc risk score for stroke and death in patients with atrial fibrillation: the prospective Danish Diet, Cancer, and Health cohort study.CHA2DS2VASc风险评分对房颤患者中风和死亡的额外预测能力：丹麦饮食、癌症和健康前瞻性队列研究
Circ Cardiovasc Qual Outcomes. 2012 May;5(3):335-42. doi: 10.1161/CIRCOUTCOMES.111.964023. Epub 2012 Apr 24.
3
Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort study.华法林在房颤患者中的净临床获益：来自瑞典房颤队列研究的报告。
Circulation. 2012 May 15;125(19):2298-307. doi: 10.1161/CIRCULATIONAHA.111.055079. Epub 2012 Apr 18.
4
Monomeric C-reactive protein alters fibrin clot properties on endothelial cells.单体 C 反应蛋白改变内皮细胞上纤维蛋白凝块的性质。
Thromb Res. 2012 May;129(5):e251-6. doi: 10.1016/j.thromres.2012.03.014. Epub 2012 Apr 2.
5
Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) substudy.心脏生物标志物与房颤患者的中风和死亡风险增加相关：随机长期抗凝治疗（RE-LY）子研究。
Circulation. 2012 Apr 3;125(13):1605-16. doi: 10.1161/CIRCULATIONAHA.111.038729. Epub 2012 Feb 28.
6
Presence of atrial fibrillation is independently associated with adverse outcomes in patients hospitalized with heart failure: an analysis of get with the guidelines-heart failure.心房颤动的存在与心力衰竭住院患者的不良预后独立相关：对 get with the guidelines-heart failure 的分析。
Circ Heart Fail. 2012 Mar 1;5(2):191-201. doi: 10.1161/CIRCHEARTFAILURE.111.965681. Epub 2012 Feb 23.
7
Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation.HAS-BLED 出血风险评分与抗凝治疗的心房颤动患者的大出血、心血管事件和死亡率的关系。
Circ Arrhythm Electrophysiol. 2012 Apr;5(2):312-8. doi: 10.1161/CIRCEP.111.967000. Epub 2012 Feb 7.
8
Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study.评估 182678 例心房颤动患者缺血性卒中和出血的风险分层方案：瑞典心房颤动队列研究。
Eur Heart J. 2012 Jun;33(12):1500-10. doi: 10.1093/eurheartj/ehr488. Epub 2012 Jan 13.
9
Subclinical atrial fibrillation and the risk of stroke.无症状性心房颤动与卒中风险。
N Engl J Med. 2012 Jan 12;366(2):120-9. doi: 10.1056/NEJMoa1105575.
10
Incidence and prevalence of atrial fibrillation and associated mortality among Medicare beneficiaries, 1993-2007.1993 - 2007年医疗保险受益人心房颤动的发病率、患病率及相关死亡率
Circ Cardiovasc Qual Outcomes. 2012 Jan;5(1):85-93. doi: 10.1161/CIRCOUTCOMES.111.962688. Epub 2012 Jan 10.
Zotero 插件